Annals of Oncology

News:

A rise in our impact factor
Ann Oncol 9: 123.
[PDF] [Request Permissions]

UK needs more cancer specialists
Ann Oncol 9: 123.
[PDF] [Request Permissions]

Free movements of patients soon reality in the EU?
Ann Oncol 9: 123.
[PDF] [Request Permissions]

Kyoto: Only a small step
Ann Oncol 9: 123-124.
[PDF] [Request Permissions]

Notwithstanding motor racing, Europe agrees to ban tobacco advertising
Ann Oncol 9: 124.
[PDF] [Request Permissions]

Cancer co-op
Ann Oncol 9: 124-125.
[PDF] [Request Permissions]

Economics and cancer
Ann Oncol 9: 125.
[PDF] [Request Permissions]

Italian furor over Di Bella
Ann Oncol 9: 125-126.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 9: 126-127.
[PDF] [Request Permissions]

Cooperation sought for gastric-MALT-lymphoma trial
Ann Oncol 9: 127.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 127-128.
[PDF] [Request Permissions]

Editorials:

R. Zittoun, A. Delmer, and B. Rio

Understanding and overcoming resistance to chemotherapy in acute myeloid leukemia
Ann Oncol 9: 129-130.
[PDF] [Request Permissions]

I. F. Khouri and M. J. Keating

High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?
Ann Oncol 9: 131-132.
[PDF] [Request Permissions]

Special articles:

M. J. Piccart

The changing landscape of breast cancer clinical research ESMO-Award lecture, ECCO-9 Hamburg, 18 September 1997
Ann Oncol 9: 133-138.
[Abstract] [PDF] [Request Permissions]

Review:

P. Baas, H. Schouwink, and F. A. N. Zoetmulder

Malignant pleural mesothelioma
Ann Oncol 9: 139-149.
[PDF] [Request Permissions]

Original articles:

S. Pavlovsky, I. Fernández, G. Milone, J. Martinez Rolón, C. Corrado, P. Desmery, C. Dignani, M. Michelet, and M. Juni

Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission
Ann Oncol 9: 151-157.
[Abstract] [PDF] [Request Permissions]

T. Karakas, U. Maurer, E. Weidmann, C. C. Miething, D. Hoelzer, and L. Bergmann

High expression of bcl-2 mRNA as a determinant of poor prognosis acute myeloid leukemia
Ann Oncol 9: 159-165.
[Abstract] [PDF] [Request Permissions]

J. Esteve, N. Villamor, D. Colomer, F. Bosch, A. López-Guillermo, M. Rovira, A. Urbano-Ispizua, J. Sierra, E. Carreras, and E. Montserrat

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution
Ann Oncol 9: 167-172.
[Abstract] [PDF] [Request Permissions]

E. K. Rowinsky, S. D. Baker, K. Burks, S. O'Reilly, R. C. Donehower, and L. B. Grochow

High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamic study
Ann Oncol 9: 173-180.
[Abstract] [PDF] [Request Permissions]

F. Pasini, G. Pelosi, G. Verlato, G. Guidi, F. Pavanel, D. Tummarello, A. Masotti, and G. L. Cetto

Positive immunostaining with MLuCl of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer
Ann Oncol 9: 181-185.
[Abstract] [PDF] [Request Permissions]

D. Dini, L. Del Mastro, A. Gozza, R. Lionetto, O. Garrone, G. Forno, G. Vidili, G. Bertelli, and M. Venturini

The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study
Ann Oncol 9: 187-190.
[Abstract] [PDF] [Request Permissions]

G. M. J. Bos, W. L. J. van Putten, B. van der Holt, M. van den Bent, L. F. Verdonck, and A. Hagenbeek Dutch HOVON group

For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory?
Ann Oncol 9: 191-194.
[Abstract] [PDF] [Request Permissions]

J.-M. Andrieu, J.-P. Jais, P. Colonna, B. Desablens, J. Brière, S. François, J.-L. Harousseau, P. Casassus, A. Lemevel, P.-Y. Le Prisé, C. Ghandour, F. Guilhot, and F. Lejeune

Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages
Ann Oncol 9: 195-203.
[Abstract] [PDF] [Request Permissions]

M. Boylan, H. W. van den Berg, and M. Lynch

The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: Growth stimulation in the presence of tamoxifen
Ann Oncol 9: 205-211.
[Abstract] [PDF] [Request Permissions]

Clinical case:

R. Lenzi, E. E. Kim, M. N. Raber, and J. L. Abbruzzese

Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by ¹¹¹ In-pentetreotide scan
Ann Oncol 9: 213-216.
[Abstract] [PDF] [Request Permissions]

Short report:

P. Ruff, M. R. Chasen, J. E. H. Long, and C. E. J. van Rensburg

A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma
Ann Oncol 9: 217-219.
[Abstract] [PDF] [Request Permissions]

P. Staib, B. Lathan, S. Knöppel-Schwark, H. Tesch, D. Voliotis, H. T. Steinmetz, M. Schwonzen, P. D. Wickramanayake, and V. Diehl

Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients
Ann Oncol 9: 221-223.
[Abstract] [PDF] [Request Permissions]

A. lop, G. Cartei, and A. Isaia

Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil
Ann Oncol 9: 225-227.
[Abstract] [PDF] [Request Permissions]

Book reviews:

A. Costa and S. Lowe

Book review
Ann Oncol 9: 228.
[PDF] [Request Permissions]

P. Krauseneck

Book review
Ann Oncol 9: 232.
[PDF] [Request Permissions]

Letters to the editor:

H. E. Lambert and G. J. S. Rustin

Consolidation therapy for advanced ovarian cancer
Ann Oncol 9: 229.
[PDF] [Request Permissions]

M. E. L. van der Berg

Consolidation therapy for advanced ovarian cancer
Ann Oncol 9: 229-230.
[PDF] [Request Permissions]

R. Herrmann

5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion
Ann Oncol 9: 230.
[PDF] [Request Permissions]

P. Ross, A. Norman, and D. Cunningham

5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion: This letter was referred to the author who respond as follows:
Ann Oncol 9: 230.
[PDF] [Request Permissions]

A. Obermair, M. Binder, M. Barrada, D. Bancher-Todesca, E. Asseryanis, and E. Kubista

Onycholysis in patients treated with docetaxel
Ann Oncol 9: 230-231.
[PDF] [Request Permissions]

J. Bernhard

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach
Ann Oncol 9: 231.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.